Hypothyroidism (ICD-11: 5A00) - Complete Clinical Coding Guide

1. Introduction

Hypothyroidism represents one of the most prevalent endocrinopathies in worldwide clinical practice, characterized by insufficient production of thyroid hormones by the thyroid gland or by inadequate response of peripheral tissues to these hormones. This condition affects multiple organ systems and can manifest in a subtle or dramatic manner, depending on the severity and speed of onset.

The clinical importance of hypothyroidism transcends simple endocrine dysfunction. When undiagnosed or inadequately treated, it can result in significant cardiovascular complications, cognitive impairment, severe metabolic alterations, and in extreme cases, progression to myxedematous coma with high mortality. The prevalence of hypothyroidism varies according to age, sex, and geographic region, being considerably more common in women and in individuals over 60 years of age.

From a public health perspective, hypothyroidism represents a considerable challenge due to its often insidious nature, which can delay diagnosis, and the need for continuous treatment throughout life in most cases. Public health systems face significant demands related to screening, laboratory diagnosis, and uninterrupted supply of hormone replacement therapy.

Correct coding of hypothyroidism using the ICD-11 system is fundamental for multiple purposes: it ensures adequate documentation of the diagnosis, facilitates accurate epidemiological studies, allows appropriate planning of health resources, ensures appropriate reimbursements in health insurance systems, and contributes to quality clinical research. The code 5A00 of ICD-11 specifically represents hypothyroidism and its correct use requires clear understanding of diagnostic criteria and distinctions in relation to other thyroid conditions.

2. Correct ICD-11 Code

Code: 5A00

Description: Hypothyroidism

Parent category: Disorders of thyroid gland or thyroid hormone system

The code 5A00 in ICD-11 encompasses all forms of hypothyroidism, regardless of specific etiology. This code represents a broad diagnostic category that includes primary hypothyroidism (due to dysfunction of the thyroid gland itself) through secondary and tertiary hypothyroidism (due to alterations in the hypothalamic-pituitary-thyroid axis).

The hierarchical structure of ICD-11 positions code 5A00 within the chapter dedicated to disorders of the thyroid gland or thyroid hormone system, reflecting its nature as a primary endocrine disorder. This classification facilitates navigation among related conditions and allows better understanding of the interrelationships between different thyroid pathologies.

It is important to note that code 5A00 has subcategories that allow for additional specification when more detailed information about the etiology or characteristics of hypothyroidism is available. The choice between using the general code 5A00 or a more specific subcategory depends on the level of diagnostic detail available at the time of coding and the documentation requirements of the specific clinical context.

3. When to Use This Code

Code 5A00 should be applied in specific clinical situations where there is laboratory or clinical confirmation of hypothyroidism. Below are detailed practical scenarios:

Scenario 1: Manifest Primary Hypothyroidism A 45-year-old patient presents with complaints of progressive fatigue, unexplained weight gain, cold intolerance, and constipation. Laboratory tests reveal elevated TSH (above the upper limit of normal) and reduced free T4. There is no history of thyroid surgery or use of medications that affect thyroid function. This is the classic scenario for application of code 5A00, representing manifest primary hypothyroidism with clinical symptomatology and unequivocal laboratory confirmation.

Scenario 2: Progressive Subclinical Hypothyroidism An asymptomatic individual or one with nonspecific symptoms presents with persistently elevated TSH on multiple measurements (generally above 10 mIU/L), but with free T4 still within the normal range. When there is a decision to initiate treatment based on clinical criteria (presence of antithyroid antibodies, subtle symptoms, dyslipidemia, planned pregnancy), code 5A00 is appropriate, documenting the condition that requires therapeutic intervention.

Scenario 3: Post-Thyroidectomy Hypothyroidism A patient who has undergone total thyroidectomy for thyroid carcinoma or voluminous goiter develops complete dependence on levothyroxine to maintain a euthyroid state. Even with adequate hormonal replacement therapy, the diagnosis of hypothyroidism remains valid, as the underlying condition persists. Code 5A00 documents this clinical reality, regardless of the therapeutic control achieved.

Scenario 4: Secondary or Central Hypothyroidism A patient with a history of pituitary adenoma treated with surgery or radiotherapy presents with low or inappropriately normal TSH associated with reduced free T4. This presentation indicates hypothyroidism of central origin (pituitary or hypothalamic), a situation in which code 5A00 remains applicable and may be complemented with additional codes that specify the pituitary etiology when available in the subcategories.

Scenario 5: Drug-Induced Hypothyroidism A patient undergoing treatment with amiodarone, lithium, or immunotherapy for cancer develops TSH elevation and free T4 reduction, with clinical manifestations compatible with hypothyroidism. Even though secondary to medication use, the condition constitutes true hypothyroidism that requires coding with 5A00, and external cause codes may be added to document the causative agent.

Scenario 6: Congenital Hypothyroidism Diagnosed Late A child or adolescent diagnosed with congenital hypothyroidism that was not identified in neonatal screening programs, presenting with developmental delay, short stature, and laboratory confirmation of thyroid hormone deficiency. Code 5A00 applies with the possibility of additional specification through subcategories that detail the congenital nature of the condition.

4. When NOT to Use This Code

It is essential to understand situations where code 5A00 should not be applied, avoiding coding errors that may compromise clinical documentation and epidemiological data.

Goiter Without Thyroid Dysfunction: Patients with volumetric enlargement of the thyroid gland (goiter) but with preserved thyroid function (normal TSH and free T4) should not receive code 5A00. These situations are appropriately coded with 5A01 (Nontoxic goiter), even if there are compressive symptoms or aesthetic concerns related to glandular volume.

Thyrotoxicosis or Hyperthyroidism: Conditions characterized by excess thyroid hormones, whether from glandular hyperactivity (Graves' disease, toxic adenoma) or excessive release of preformed hormones (early phase subacute thyroiditis), require coding with 5A02 (Thyrotoxicosis). Confusion may occur when patients with thyrotoxicosis are treated with ablative therapies and subsequently develop hypothyroidism, a situation in which the transition of codes should be documented temporally.

Thyroiditis in Euthyroid Phase: Patients with autoimmune thyroiditis (Hashimoto) or other forms of thyroiditis who still maintain normal thyroid function should not receive code 5A00. While function remains preserved laboratorially, the appropriate code is 5A03 (Thyroiditis NOS) or more specific thyroiditis subcategories. Code 5A00 becomes applicable only when there is progression to manifest or subclinical hypothyroidism.

Euthyroid Sick Syndrome: Severely ill patients from non-thyroidal conditions frequently present alterations in thyroid function tests (typically low T3, normal or low T4, normal or low TSH) without true hypothyroidism. This syndrome, also known as nonthyroidal illness syndrome, should not be coded as 5A00, as it represents physiological adaptation to severe systemic disease and generally resolves with recovery of the underlying condition.

Thyroid Hormone Resistance: This rare genetic condition is characterized by elevated levels of thyroid hormones with normal or elevated TSH due to mutations in hormone receptors. Despite potentially presenting some clinical features that overlap with hypothyroidism, it represents a distinct entity that requires specific coding different from 5A00.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of hypothyroidism diagnosis requires integration of clinical and laboratory data. Clinically, one should investigate symptoms such as fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, menstrual alterations, bradycardia, and cognitive slowing. On physical examination, myxedema, tendon reflexes with prolonged relaxation phase, bradycardia, and hypothermia may be present.

Laboratory diagnosis is based primarily on TSH and free T4 measurement. In overt primary hypothyroidism, TSH is elevated and free T4 is reduced. In subclinical hypothyroidism, TSH is elevated but free T4 remains normal. In central hypothyroidism, both TSH and free T4 are low or TSH is inappropriately normal in the face of reduced free T4.

Complementary investigations may include measurement of antithyroid antibodies (anti-TPO and anti-thyroglobulin) to identify autoimmune etiology, thyroid ultrasonography to assess morphological characteristics of the gland, and evaluation of other hormonal axes when central hypothyroidism is suspected.

Step 2: Verify Specifiers

After diagnostic confirmation, specific aspects of hypothyroidism that may influence detailed coding should be characterized. Severity may be classified as subclinical (elevated TSH, normal free T4), mild to moderate overt (elevated TSH, reduced free T4, symptoms present but not limiting) or severe (incapacitating symptoms, risk of myxedematous coma).

Duration should be documented when known, differentiating acute or subacute cases (such as postpartum thyroiditis) from permanent chronic hypothyroidism. Etiology, when identified, adds diagnostic value: autoimmune (Hashimoto's thyroiditis), iatrogenic (post-surgery, post-radioiodine, drug-induced), congenital, or secondary to infiltrative diseases.

Special characteristics such as hypothyroidism in pregnancy, hypothyroidism in patients with significant cardiovascular comorbidities, or hypothyroidism refractory to conventional treatment should be documented, as they may influence therapeutic decisions and justify additional coding.

Step 3: Differentiate from Other Codes

5A01 (Nontoxic goiter): The fundamental difference lies in the presence or absence of hormonal dysfunction. While 5A00 requires evidence of thyroid hormone deficiency (elevated TSH in primary hypothyroidism), code 5A01 applies when there is thyroid volume increase but preserved hormonal function. Patients may transition from 5A01 to 5A00 if they develop hypothyroidism over time.

5A02 (Thyrotoxicosis): This differentiation is generally clear, as it represents the functional opposite of hypothyroidism. While 5A00 is characterized by hormonal deficiency (elevated TSH, reduced T4 in primary), 5A02 presents with hormonal excess (suppressed TSH, elevated T4 and/or T3). Special attention is needed in transition phases, such as subacute thyroiditis that may evolve from initial thyrotoxicosis to transient hypothyroidism.

5A03 (Thyroiditis NEC): The distinction is based on the presence of hypofunction. Thyroiditis without associated hypothyroidism should be coded as 5A03. When thyroiditis results in permanent or prolonged hypothyroidism, both codes may be relevant, but 5A00 becomes the primary functional diagnosis. In Hashimoto's thyroiditis with hypothyroidism, 5A00 is the principal code that documents the functional consequence.

Step 4: Required Documentation

Adequate documentation to support code 5A00 should include:

Mandatory Checklist:

Laboratory results with numerical values of TSH and free T4
Date of tests and reference ranges of the laboratory used
Description of clinical symptoms present
Relevant physical examination findings
History of conditions or treatments that may cause hypothyroidism
Presence of antithyroid antibodies when measured
Medications in use, especially levothyroxine and doses
Relevant comorbidities that influence management

Adequate Record: The medical record should clearly document the temporal evolution of the condition, response to previous treatments when applicable, and justification for therapeutic decisions. In cases of subclinical hypothyroidism, documentation should explain the decision to treat or monitor, based on factors such as TSH level, presence of symptoms, positive antibodies, or associated conditions such as dyslipidemia or infertility.

6. Complete Practical Example

Clinical Case

A 52-year-old female patient presents to the consultation reporting progressive fatigue over the past eight months, associated with weight gain of approximately 7 kg without significant changes in diet or physical activity. She also reports cold intolerance ("always cold while others are comfortable"), intestinal constipation that has worsened recently, skin drier than usual, and menstrual irregularity with more spaced cycles. She denies previous surgeries, regular medication use, or radiation exposure. Family history reveals mother with "thyroid problem" under treatment.

On physical examination: weight 72 kg, height 1.62 m, BMI 27.4 kg/m², blood pressure 118/76 mmHg, heart rate 58 bpm, axillary temperature 35.8°C. Dry skin to touch, brittle hair. Thyroid not palpable, without evident nodules. Achilles reflexes with slowed relaxation phase. Discrete periorbital edema. Remainder of examination unremarkable.

Laboratory tests ordered:

TSH: 18.5 mIU/L (reference: 0.4-4.0 mIU/L)
Free T4: 0.7 ng/dL (reference: 0.9-1.8 ng/dL)
Anti-TPO: 450 IU/mL (reference: <35 IU/mL)
Total cholesterol: 265 mg/dL
LDL: 175 mg/dL

Thyroid ultrasound: gland of normal dimensions, heterogeneous echotexture with multiple hypoechoic areas, compatible with chronic thyroiditis. No nodules.

Coding Step by Step

Criteria Analysis:

The case presents unequivocal confirmation of manifest primary hypothyroidism. The diagnostic criteria are clearly satisfied: significantly elevated TSH (18.5 mIU/L, more than four times the upper limit of normal) associated with reduced free T4 (0.7 ng/dL, below the lower limit). The clinical presentation is typical, with multiple characteristic symptoms of hypothyroidism: fatigue, weight gain, cold intolerance, constipation, dry skin, bradycardia, hypothermia, and slowed reflexes.

Autoimmune etiology is strongly suggested by the presence of markedly elevated anti-TPO antibodies and ultrasound findings compatible with Hashimoto thyroiditis. The positive family history for thyroid disease reinforces genetic predisposition. There is no evidence of secondary or iatrogenic causes.

Code Selected: 5A00

Complete Justification:

The code 5A00 (Hypothyroidism) is the appropriate primary code for this case. The patient presents with manifest primary hypothyroidism of autoimmune etiology (Hashimoto thyroiditis), with unequivocal laboratory confirmation and compatible clinical symptomatology. The elevated TSH with reduced free T4 characterizes manifest hypothyroidism, distinguishing it from subclinical hypothyroidism where free T4 would remain normal.

Coding with 5A00 adequately documents the functional condition of the thyroid and justifies the need for treatment with levothyroxine. 5A01 (Nontoxic goiter) is not used because there is evident hormonal dysfunction, not merely volumetric alteration. 5A02 (Thyrotoxicosis) does not apply as there is hormone deficiency, not excess. Although there is evidence of autoimmune thyroiditis, the functional code 5A00 is more appropriate than 5A03 (Thyroiditis NEC) because it documents the permanent functional consequence of thyroiditis.

Complementary Codes:

Depending on the coding system used and institutional requirements, additional codes may be considered:

Code for dyslipidemia secondary to hypothyroidism
Code for obesity if applicable according to BMI criteria
Possible specifier for autoimmune etiology if available in subcategories

Documented Therapeutic Plan:

Levothyroxine 50 mcg initiated in the morning on an empty stomach. Laboratory reevaluation requested (TSH and free T4) in 6-8 weeks for dose adjustment. Guidance provided on the importance of treatment adherence, administration on an empty stomach, and need for continuous follow-up. Patient informed of expectation of gradual symptom improvement over the coming weeks to months. Return visit scheduled for discussion of results and therapeutic adjustment.

7. Related Codes and Differentiation

Within the Same Category

5A01: Nontoxic goiter

When to use vs. 5A00: Code 5A01 applies when there is an increase in thyroid gland volume (goiter) but hormonal function remains preserved, with TSH and free T4 within normal limits. Use 5A00 when there is laboratory evidence of thyroid hypofunction, regardless of gland volume.

Main difference: The fundamental distinction is functional, not anatomical. A patient may have voluminous goiter with normal function (5A01) or normal-sized thyroid with hypofunction (5A00). When goiter and hypothyroidism coexist, 5A00 is the primary code as it documents the functional dysfunction requiring hormonal treatment, although goiter characteristics should be documented clinically.

5A02: Thyrotoxicosis

When to use vs. 5A00: Code 5A02 is applied in situations of excess thyroid hormones, characterized by suppressed TSH and elevation of free T4 and/or T3. It represents the functional opposite of hypothyroidism. Use 5A00 when there is thyroid hormone deficiency.

Main difference: The differentiation is based on laboratory and clinical pattern. Thyrotoxicosis (5A02) presents with hypermetabolic symptoms (tachycardia, weight loss, heat intolerance, tremors), while hypothyroidism (5A00) manifests with hypometabolic symptoms (bradycardia, weight gain, cold intolerance, psychomotor slowing). Special situations include subacute thyroiditis where an initial phase of thyrotoxicosis may be followed by transient hypothyroidism, requiring coding change according to disease progression.

5A03: Thyroiditis NOS

When to use vs. 5A00: Code 5A03 documents inflammatory processes of the thyroid gland without specifying the functional state. It is used when thyroiditis is present but thyroid function remains normal. Code 5A00 becomes appropriate when thyroiditis results in permanent or prolonged hypofunction.

Main difference: The distinction centers on functional consequence. Hashimoto thyroiditis in early phase with positive antibodies but preserved function justifies 5A03. When the same condition progresses with elevated TSH and reduced T4, 5A00 becomes the primary code. In subacute thyroiditis, coding may transition from 5A03 (acute inflammatory phase) to 5A02 (thyrotoxic phase) and eventually 5A00 (hypothyroid phase), documenting the temporal evolution of the disease.

Differential Diagnoses

Euthyroid Sick Syndrome: Critically ill patients frequently present alterations in thyroid tests that mimic hypothyroidism but represent physiological adaptation. It is differentiated by the presence of severe systemic disease, characteristic laboratory pattern (low T3, normal-low T4, normal-low TSH), and normalization after recovery from the underlying disease, without need for specific thyroid treatment.

Major Depression: May present with overlapping symptoms with hypothyroidism (fatigue, weight gain, psychomotor slowing, difficulty concentrating). Differentiation requires thyroid laboratory evaluation. Patients with depression have normal thyroid function, while hypothyroidism presents with characteristic laboratory alterations.

Cushing Syndrome: May share symptoms such as weight gain, fatigue, and depression. It is differentiated by the presence of specific features (moon facies, violaceous striae, centripetal fat redistribution) and specific laboratory tests for cortisol.

Iron Deficiency Anemia: Fatigue and exercise intolerance may suggest hypothyroidism, but laboratory evaluation clearly differentiates the conditions. Complete blood count and iron studies are diagnostic for anemia, while thyroid function tests are normal.

8. Differences with ICD-10

In ICD-10, hypothyroidism was coded primarily as E03, with specific subdivisions: E03.0 (Congenital hypothyroidism with diffuse goiter), E03.1 (Congenital hypothyroidism without goiter), E03.2 (Hypothyroidism due to medications and other exogenous substances), E03.3 (Post-infectious hypothyroidism), E03.4 (Acquired thyroid atrophy), E03.5 (Myxedematous coma), E03.8 (Other specified hypothyroidism), and E03.9 (Unspecified hypothyroidism).

ICD-11 simplifies and reorganizes this structure with code 5A00, offering a more intuitive and hierarchically organized system. The main conceptual change lies in the coding structure: while ICD-10 required selection among multiple E03.x codes based on specific etiological characteristics, ICD-11 allows use of the primary code 5A00 with the possibility of additional specifiers through extensions and complementary codes.

This change impacts clinical practice by facilitating initial coding, as the base code 5A00 is applicable to most cases of hypothyroidism regardless of etiology. Etiological details can be added when known, but are not mandatory for basic coding. This flexibility is particularly useful in primary care settings where detailed etiological investigations may not be immediately available.

The transition from ICD-10 to ICD-11 also improves compatibility with electronic health systems, allowing better epidemiological tracking and facilitating international comparative studies. Professionals familiar with ICD-10 E03.x codes should adapt to the new system, recognizing that 5A00 encompasses most situations previously coded with different E03 subcategories.

9. Frequently Asked Questions

How is hypothyroidism diagnosed?

The diagnosis combines clinical and laboratory evaluation. Clinically, symptoms such as fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, and cognitive slowing are investigated. Laboratorially, TSH measurement is the initial screening test. Elevated TSH suggests primary hypothyroidism and should be confirmed with free T4 measurement. In overt hypothyroidism, TSH is elevated and free T4 is reduced. In subclinical hypothyroidism, TSH is elevated but free T4 remains normal. Complementary tests such as antithyroid antibodies and ultrasound can identify the cause, but are not mandatory for functional diagnosis.

Is treatment available in public health systems?

Yes, hypothyroidism treatment with levothyroxine is widely available in public health systems in most countries. Levothyroxine is considered essential medication by the World Health Organization and is generally included in lists of basic medications provided free of charge or at subsidized cost. Treatment is relatively accessible due to the low cost of medication and availability of generic formulations. Periodic laboratory monitoring with TSH measurements is also usually available through public systems, although waiting times may vary by region and local demand.

How long does treatment last?

In most cases, hypothyroidism requires continuous treatment throughout life. Exceptions include transient hypothyroidism post-subacute thyroiditis, drug-induced hypothyroidism that may resolve after discontinuation of the causative agent, and postpartum hypothyroidism that may be temporary. Treatment with levothyroxine is generally well tolerated, with dose adjustments made based on periodic laboratory monitoring. After dose stabilization, annual evaluations are often sufficient in patients without complications. It is essential not to discontinue treatment without medical guidance, as discontinuation may result in symptomatic recurrence and complications.

Can this code be used in medical certificates?

Yes, code 5A00 can be used in official medical documentation, including certificates, reports, and disability documents when appropriate. However, the context and purpose of the document should be considered. For work absences related to hypothyroidism, generally the condition itself does not justify prolonged disability after treatment initiation, except in severe cases such as myxedema coma or severe uncontrolled hypothyroidism. Documentation should focus on specific functional consequences that justify the absence, not just the coded diagnosis. In benefit requests or disability evaluations, coding should be accompanied by detailed description of severity and functional impact.

Does subclinical hypothyroidism always need treatment?

Not necessarily. The decision to treat subclinical hypothyroidism (elevated TSH with normal free T4) is individualized, considering multiple factors: TSH level (values above 10 mIU/L have greater indication for treatment), presence of compatible symptoms, positivity of antithyroid antibodies, presence of goiter, pregnancy planning, associated dyslipidemia, and patient preference. In cases with mildly elevated TSH (4-10 mIU/L), negative antibodies, and absence of symptoms, monitoring without immediate treatment may be appropriate, with periodic reevaluations to detect progression. Coding with 5A00 is valid even when monitoring without immediate treatment is chosen.

Can hypothyroidism cause infertility?

Yes, untreated or inadequately controlled hypothyroidism can affect fertility in women and men. In women, it can cause menstrual irregularity, anovulation, and increased risk of miscarriage. In men, it can reduce libido and sperm quality. Adequate treatment with TSH normalization generally restores fertility. Women of reproductive age with difficulty conceiving should be evaluated for thyroid dysfunction. During pregnancy, levothyroxine requirements generally increase, requiring dose adjustments and more frequent monitoring to ensure adequate fetal development.

Is there a relationship between hypothyroidism and heart disease?

Yes, there is a significant relationship. Untreated hypothyroidism increases cardiovascular risk through multiple mechanisms: elevation of LDL cholesterol, endothelial dysfunction, increased diastolic blood pressure, and reduced cardiac contractility. Severe hypothyroidism can cause pericardial effusion and heart failure. Adequate treatment generally improves these cardiovascular parameters. However, in patients with established coronary artery disease, treatment initiation should be cautious, with low initial doses and gradual titration, as abrupt increase in metabolism may precipitate ischemic events. This situation requires careful documentation and may justify additional coding for cardiovascular comorbidities.

How to differentiate symptoms of hypothyroidism from normal aging?

This differentiation can be challenging, especially in elderly patients, as symptoms such as fatigue, weight gain, cognitive slowing, and cold intolerance may be attributed to aging. The key is objective laboratory evaluation: symptoms of normal aging do not occur with elevated TSH and reduced free T4. Periodic screening of thyroid function is recommended in elderly patients, particularly women, even in the absence of specific symptoms. When hypothyroidism is identified and treated in elderly patients, significant improvement in symptoms previously attributed to aging is often observed, evidencing the importance of correct diagnosis. Coding with 5A00 documents the treatable condition, differentiating it from physiological changes of aging.

Conclusion: Appropriate coding of hypothyroidism with ICD-11 code 5A00 requires clear understanding of diagnostic criteria, differentiation of similar conditions, and appropriate documentation. This guide provides a practical basis for correct code application in various clinical contexts, contributing to accurate documentation, effective communication among professionals, and reliable epidemiological data that support public health policies and clinical research.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Hypothyroidism

Compartilhar